SCHEMBL14434817

SCHEMBL14434817

Cc1ccc2sc(C)[n+](C)c2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.61
▸ KDM4E B2RXH2 6/20 0.61
▸ ALDH1A1 P00352 4/20 0.61
▸ TDP1 Q9NUW8 2/20 0.61
▸ INSR P06213 2/20 0.48
▸ THRB P10828 2/20 0.45
▸ RECQL P46063 1/20 0.45
▸ LMNA P02545 1/20 0.44
▸ GAA P10253 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ APP P05067 2/20 0.38
▸ SNCA P37840 2/20 0.38
▸ TNF P01375 1/20 0.38
▸ NOD1 Q9Y239 1/20 0.38
▸ RAB9A P51151 2/20 0.37
▸ BCHE P06276 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL31063683 0.98 MAPT (0.64) MAPTKDM4EALDH1A1TDP1INSR
SCHEMBL11515558 0.83 MAPT (0.58) MAPTKDM4EALDH1A1TDP1INSR
Iodide SCHEMBL31063723 0.82 MAPT (0.61) MAPTKDM4EALDH1A1TDP1INSR
SCHEMBL14982704 0.81 MAPT (0.45) MAPTKDM4EALDH1A1TDP1INSR
Iodide SCHEMBL4013003 0.79 MAPT (0.60) MAPTKDM4EALDH1A1TDP1INSR
Iodide SCHEMBL31063757 0.79 MAPT (0.60) MAPTKDM4EALDH1A1TDP1INSR
SCHEMBL8032355 0.77 MAPT (0.97) MAPTKDM4EALDH1A1TDP1INSR
Iodide SCHEMBL4015595 0.76 MAPT (1.00) MAPTKDM4EALDH1A1TDP1INSR
SCHEMBL839316 0.76 MAPT (0.52) MAPTKDM4EALDH1A1TDP1INSR
SCHEMBL30411778 0.76 MAPT (0.52) MAPTKDM4EALDH1A1TDP1INSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9850382-B1 Unsymmetrical cyanine dyes and their application Ying, Laiqiang (US) 2017-12-26 — — US disclosed
US-8742114-B2 Nucleic acid detections and methods of their use Ying, Laiqiang (US) 2014-06-03 — — US disclosed
US-20130137875-A1 NUCLEIC ACID DETECTIONS AND METHODS OF THEIR USE Ying, Laiqiang (US) 2013-05-30 — — US disclosed
WO-2007090765-A2 HIGH CAPACITY OPTICAL STORAGE MEDIA COMPRISING ORGANOMETALLIC ION PAIRS CIBA HOLDING INC. (CH) 2007-08-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137875-A1 NUCLEIC ACID DETECTIONS AND METHODS OF THEIR USE DDB1, DNTT, DNA2 MAPT 3684/4885KDM4E 4421/4885ALDH1A1 4104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback